Quick Info
| Profession | Investor, former hedge fund manager and pharmaceutical executive |
|---|---|
| Nationality | American |
| Date of Birth | 17/03/1983 |
| Age | 43 years |
| Birthplace | Brooklyn, New York City, USA |
| Zodiac Sign | Pisces |
Latest News about Martin Shkreli
The Federal Trade Commission and seven states asked a federal judge to hold Martin Shkreli in contempt for allegedly violating his 2022 lifetime ban from the pharmaceutical industry. The filing says he traded shares in pharmaceutical companies and broadcast investment opinions on livestreams, and it seeks divestment of his pharma holdings, repayment of trading profits, and escalating penalties for future breaches.
Bloomberg Law reported that Shkreli has been publicly active since his 2022 release from prison, hosting livestreams offering stock-trading advice and consulting for a photonics company. He also formally asked the White House for a pardon so he could return to the pharmaceutical industry.
Do you like Martin Shkreli?
You can vote only once.
73% like · 27% dislike
Bio/Wiki
| Summary | Martin Shkreli is an American investor and businessman known for co-founding hedge funds and serving as CEO of Retrophin and Turing Pharmaceuticals. He drew public attention in 2015 for raising the price of the drug Daraprim. He was convicted of securities fraud in 2017 and was released from prison in 2022. In 2022 a federal court barred him from the pharmaceutical industry for life. |
|---|---|
| Nickname | Pharma Bro |
Educational Qualification(s)
| Schools | Hunter College High School |
|---|---|
| Colleges | Baruch College, Bachelor of Business Administration |
Personal Life
| Notes | Reported romantic relationships include Christie Smythe, a former Bloomberg News reporter, and Madison Campbell, CEO of Leda Health. |
|---|
Relationships & More
| Romantic Partners |
|
|---|
Career
| Early Career | Began working on Wall Street in 2000 as an intern at Cramer Berkowitz, and later worked there as an analyst. |
|---|---|
| Notable Roles |
|
| Legal Matters | Convicted of securities fraud in 2017 and sentenced to seven years in prison. In 2022 a federal court ordered him to return profits and barred him from the pharmaceutical industry for life. In October 2026, the Federal Trade Commission and seven states asked a federal judge to hold him in contempt for allegedly violating that ban. |
Some Lesser Known Facts
| 1. He began his Wall Street career as an intern at the age of 17. | |
| 2. He was publicly criticised for raising the price of Daraprim by about 5,000 percent in 2015. | |
| 3. A death hoax about him circulated in early October 2026 and was reported as false; he is alive. |
Social Media